newsfilter
← Latest News
PR Newswire·

Number of shares and votes in BioArctic AB (publ) as of August 31, 2026

  • BioArctic AB issued 20,200 Class B shares in August 2026 to fulfill stock option exercises from the 2019/2028 program.
  • The total share count as of August 31, 2026, stands at 88,744,685, comprising 74,344,689 listed Class B shares & 14,399,996 unlisted Class A shares.
  • Voting rights are structured with Class A shares holding ten votes per share & Class B shares holding one vote per share, totaling 218,344,649 votes.
  • BioArctic is a Swedish biopharma company developing treatments for neurodegenerative diseases, including Leqembi® for Alzheimer's disease in partnership with Eisai.
  • The company's portfolio includes antibodies for Parkinson's disease & ALS, utilizing its proprietary BrainTransporter™ technology to cross the blood-brain barrier.
  • BioArctic's Class B shares (BIOA B) are listed on Nasdaq Stockholm Large Cap, & this disclosure was made public on August 31, 2026, at 5:30pm CEST.